StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Alendronic Acid → N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

HRID 39266
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 39266
[CH2:1](CN)[CH2:2][C:3]([P:9]([OH:12])(O)=O)([P:5](O)(O)=[O:6])O.CCN([CH:21]([CH3:23])[CH3:22])C(C)C.CN(C(ON1N=NC2C=C[CH:37]=[CH:38][C:33]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51].CN([CH:71]=[O:72])C>C(OCC)(=O)C>[CH2:61]([P:5]([CH:3]([P:9]([CH2:23][CH:21]=[CH2:22])([CH2:33][CH:38]=[CH2:37])=[O:12])[CH2:2][CH2:1][C:71]([NH:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51])=[O:72])([CH2:60][CH:55]=[CH2:56])=[O:6])[CH:53]=[CH2:54]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 2088Alendronic AcidHCID 6228DimethylformamideHCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 6992441Glycyl-phenylalanyl-glycine

Produkt 1

HCID 87302179
N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8857Ethyl AcetateLösungsmittel

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

To a solution of bisphosphonate 8 (400 mg, 0.98 mmol) in DMF (5 mL) at 0° C. was added DIEA (341 μL, 1.96 mmol) and HBTU (372 mg, 0.98 mmol). After stirring for 10 min at 0° C., the resulting activated ester solution was added to crude tripeptide 75 (0.98 mmol) and stirring was pursued for 2.5 h at 0° C. The reaction mixture was diluted with ethyl acetate, washed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution. The organic layer was dried over MgSO4, filtered and concentrated to dryness. The crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system using a gradient of 0-10% methanol in ethyl acetate. Compound 76 was obtained as a colorless gum (652 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 2.22-2.37 (m, 2H), 2.57 (t, J=6.4 Hz, 2H), 2.62 (tt, J=23.9, 7.0 Hz, 1H), 3.03-3.09 (m, 1H), 3.14-3.20 (m, 1H), 3.77-3.93 (m, 4H), 4.58-4.63 (m, 8H), 4.66-4.71 (m, 1H), 5.21-5.26 (m, 4H), 5.33-5.41 (m, 4H), 5.89-5.99 (m, 4H), 6.58-6.66 (m, 2H), 7.09 (d, J=8.2, 1H), 7.19-7.23 (m, 3H), 7.27-7.30 (m, 2H).

Aufarbeitung

  1. stirringstirring
  2. waitwas pursued for 2.5 h at 0° C
  3. washwashed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution
  4. dry with materialThe organic layer was dried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated to dryness
  7. customThe crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system

Quellen und Nachweise

ORD-Eintrag
ord-ff1ade8889734ef28619030a99ed52be
Quelldatensatz
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08524691B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion